ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657305 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657305; 2) Community: the network communities that were significantly associated with the response to NSC 657305; 3) Molecule: the relationships between components within communities and NSC 657305; 4) MDR: the compounds that were significantly associated with the NSC 657305.

NSC Compound Enrichment Correlation
NSC 75140 Benzenesulfonamide, 4-[(6,7-dihydro-6-thioxo-1H-purin-8-yl)azo]- 0.0382675857669588 0.13250422
NSC 754824 4-[4-(3-Methoxy-phenyl)-piperazin-1 -yl]-5H-pyrrolo[3,2-d]pyrimidine 0.0382675857669588 0.28482622
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 0.0382675857669588 0.37378029
NSC 95382 Camptothecin Derivative 0.0382675857669588 0.38198618
NSC 658469 1,3-dimethyl-2,4-dioxo(1H,3H)pyrimido dimethyltetrathiafulvalene 0.0414190425892865 0.059099992
NSC 666112 Null 0.0414190425892865 0.13044333
NSC 670226 trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid 0.0414190425892865 0.24761183
NSC 670284 Null 0.0414190425892865 0.29808763
NSC 672116 9-.alpha.-Acetoxyparthenolide 0.0414190425892865 0.10743149
NSC 673456 Null 0.0414190425892865 0.26323408
Total:71  Current:60    [First] [Prev] [Next] [Last]